Depo-Medrol

Pfizer is a leading global biopharmaceutical company that discovers, develops, and manufactures healthcare products, including medicines and vaccines. The company operates through several segments, focusing on oncology, immunology, cardiology, and rare diseases. Depo-Medrol, a brand name for methylprednisolone acetate, is one of Pfizer's widely used injectable corticosteroid products indicated for various inflammatory and autoimmune conditions. Pfizer is a publicly traded entity and maintains a robust pipeline of innovative therapies across multiple modalities, ranging from small molecules to advanced mRNA technology. Headquartered in New York City, the company has a significant global footprint with research and manufacturing facilities worldwide. Pfizer continues to expand its portfolio through strategic acquisitions, such as the recent integration of Seagen to enhance its oncology capabilities.